| CASE REPORT |
|
| Year : 2016 | Volume
: 5
| Issue : 4 | Page : 875-878 |
|
|
Low-dose methotrexate-induced acute interstitial pneumonitis: Report of two cases from South India and review of literature
Ramya Iyyadurai, Ronald Albert Benton Carey, Sowmya Satyendra
Department of Medicine, Christian Medical College, Vellore, Tamil Nadu, India
Correspondence Address:
Ramya Iyyadurai
Department of Medicine, Christian Medical College, Vellore - 632 004, Tamil Nadu
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2249-4863.201163
|
|
|
Methotrexate (MTX) is an antimetabolite used as a disease-modifying agent for various rheumatological conditions. We report two patients who were treated with daily low-dose MTX and developed acute interstitial pneumonitis requiring hospital admission. MTX-induced pneumonitis is a rare life-threatening side effect, high index of clinical suspicion is required, treatment is mainly withdrawal of MTX, supportive therapy, and adjunctive steroids, outcome is good if condition is recognized early, and appropriate treatment is given. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
